Harbin Pharmaceutical Hits Two-Day Limit-Up Streak, Gaining 20.9%
Harbin Pharmaceutical Group Co. , Ltd. shares hit the daily price limit for two consecutive trading sessions, completing a two-board limit-up pattern. Over the two sessions, the stock recorded a cumulative gain of 20.9%. The successive limit-up sessions lifted the company's share price significantly in a short period, reflecting sustained buying interest in the stock during the latest trading days.
Harbin Pharmaceutical Group Co. , Ltd. shares hit the daily price limit for two consecutive trading sessions, completing a two board limit-up streak. The stock's cumulative gain over the two days reached 20.9%.